BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8420788)

  • 1. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
    Pranzatelli MR; Murthy JN; Tailor PT
    Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
    Pranzatelli MR; Tailor PT
    Gen Pharmacol; 1994 Oct; 25(6):1279-84. PubMed ID: 7875557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR; Murthy JN; Pluchino RS
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA; Ageel AM; Ginawi OT
    Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium.
    Esterle TM; Sanders-Bush E
    J Neurosci; 1992 Dec; 12(12):4775-82. PubMed ID: 1334504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Aulakh CS; Hill JL; Yoney HT; Murphy DL
    Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations.
    Bagdy G; Kalogeras KT; Szemeredi K
    Eur J Pharmacol; 1992 Dec; 229(1):9-14. PubMed ID: 1473565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 5-HT1C-receptors in drug-induced penile erections in rats.
    Berendsen HH; Jenck F; Broekkamp CL
    Psychopharmacology (Berl); 1990; 101(1):57-61. PubMed ID: 2343074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
    Claustre Y; Eudeline B; Benavides J; Scatton B
    Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
    Kłodzińska A; Jaros T; Chojnacka-Wójcik E; Maj J
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):207-18. PubMed ID: 2775468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced regulation of [125I]iodocyanopindolol-labeled 5-hydroxytryptamine1B receptor binding sites in the central nervous system.
    Pranzatelli MR; Razi P
    Neuropsychopharmacology; 1994 Jul; 10(4):259-64. PubMed ID: 7945736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
    Jenck F; Broekkamp CL; Van Delft AM
    Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.